Vasodilator stress perfusion CMR imaging is feasible and prognostic in obese patients

JACC: Cardiovascular Imaging

Volumn 7, Issue 5, 2014, Pages 462-472

  Shah, Ravi V ^a,b   Heydari, Bobak ^a   Coelho Filho, Otavio ^c   Abbasi, Siddique A ^a   Feng, Jiazhuo H ^a   Neilan, Tomas G ^a,b   Francis, Sanjeev ^b   Blankstein, Ron ^a   Steigner, Michael ^a   Jerosch Herold, Michael ^a   Kwong, Raymond Y ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

cardiac magnetic resonance; obesity; stress testing

Indexed keywords

CONTRAST ENHANCEMEN; GADOLINIUM; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE QUALITY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; OBESITY; PRIORITY JOURNAL; PROGNOSIS; SEDATION; STRESS; COMPLICATION; DIAGNOSTIC USE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY;

BODY MASS INDEX; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OBESITY; PROGNOSIS; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 84900414192     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.11.011     Document Type: Article

References (27)

1. C.L. Ogden, M.D. Carroll, L.R. Curtin, M.A. McDowell, C.J. Tabak, and K.M. Flegal Prevalence of overweight and obesity in the United States, 1999-2004 JAMA 295 2006 1549 1555
2. R.P. Bogers, W.J. Bemelmans, R.T. Hoogenveen for the BMI-CHD Collaboration Investigators Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: A meta-analysis of 21 cohort studies including more than 300 000 persons Arch Intern Med 167 2007 1720 1728
3. Prospective Studies Collaboration, G. Whitlock, S. Lewington, and P. Sherliker et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Lancet 373 2009 1083 1096
4. E.G. DePuey 3rd How to detect and avoid myocardial perfusion SPECT artifacts J Nucl Med 35 1994 699 702
5. J.P. Dunn, M.M. Huizinga, R. See, and W.N. Irani Choice of imaging modality in the assessment of coronary artery disease risk in extreme obesity Obesity (Silver Spring) 18 2010 1 6
6. A.J. Einstein, S.D. Weiner, and A. Bernheim et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging JAMA 304 2010 2137 2144
7. R.C. Thompson, G.V. Heller, and L.L. Johnson et al. Value of attenuation correction on ECG-gated SPECT myocardial perfusion imaging related to body mass index J Nucl Cardiol 12 2005 195 202
8. L.J. Shaw, J. Hausleiter, and S. Achenbach et al. Coronary computed tomographic angiography as a gatekeeper to invasive diagnostic and surgical procedures: results from the multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry J Am Coll Cardiol 60 2012 2103 2114
9. W.L. Duvall, L.B. Croft, and J.S. Corriel et al. SPECT myocardial perfusion imaging in morbidly obese patients: image quality, hemodynamic response to pharmacologic stress, and diagnostic and prognostic value J Nucl Cardiol 13 2006 202 209
10. K. Yoshinaga, B.J. Chow, and K. Williams et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 48 2006 1029 1039
11. B. Heydari, M. Jerosch-Herold, and R.Y. Kwong Assessment of myocardial ischemia with cardiovascular magnetic resonance Prog Cardiovasc Dis 54 2011 191 203
12. A.T. Yan, A.J. Shayne, and K.A. Brown et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality Circulation 114 2006 32 39
13. M.D. Cerqueira, N.J. Weissman, and V. Dilsizian et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542
14. J. Schwitter, C.M. Wacker, and N. Wilke et al. MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: A comparative multicentre, multivendor trial Eur Heart J 34 2013 775 781
15. J. Schwitter, C.M. Wacker, and A.C. van Rossum et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial Eur Heart J 29 2008 480 489
16. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195
17. D. Poldermans, P.M. Fioretti, and E. Boersma et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience Circulation 99 1999 757 762
18. A. Elhendy, A.F. Schinkel, and R.T. van Domburg et al. Prognostic stratification of obese patients by stress 99mtc-tetrofosmin myocardial perfusion imaging J Nucl Med 47 2006 1302 1306
19. J.M. Miller, C.E. Rochitte, and M. Dewey et al. Diagnostic performance of coronary angiography by 64-row CT New Engl J Med 359 2008 2324 2336
20. T.M. Labounty, M.J. Gomez, and S. Achenbach et al. Body mass index and the prevalence, severity, and risk of coronary artery disease: An international multicentre study of 13,874 patients Eur Heart Journal Cardiovasc Imaging 14 2013 456 463
21. A. Wagner, H. Mahrholdt, and T.A. Holly et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study Lancet 361 2003 374 379
22. M.J. Lipinski, C.M. McVey, J.S. Berger, C.M. Kramer, and M. Salerno Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: A systematic review and meta-analysis J Am Coll Cardiol 62 2013 826 838
23. S. Kelle, E. Nagel, and A. Voss et al. A bi-center cardiovascular magnetic resonance prognosis study focusing on dobutamine wall motion and late gadolinium enhancement in 3,138 consecutive patients J Am Coll Cardiol 61 2013 2310 2312
24. E.B. Schelbert, J.J. Cao, and S. Sigurdsson et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults JAMA 308 2012 890 896
25. R.Y. Kwong, A.K. Chan, and K.A. Brown et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease Circulation 113 2006 2733 2743
26. L.J. Shaw, D.S. Berman, and D.J. Maron et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 117 2008 1283 1291
27. R. Shah, B. Heydari, and O. Coelho-Filho et al. Stress cardiac magnetic resonance imaging provides effective cardiac risk reclassification in patients with known or suspected stable coronary artery disease Circulation 128 2013 605 614